In turn, chronic DRN neuron activation or chronic intranasal administration of 5-HT improves hepatic lipid metabolism, reduces liver steatosis, and ameliorates systemic (muscle) tolerance to glucose, and hepatic and systemic (muscle) sensitivity to insulin 93,97. This evidence concerns the gene INS and fatty liver disease.